People · Operator
Named in public records as an officer, director or promoter · active 2009–2011 · Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Insight Pharmaceuticals Corp | — | Other | Series C | $102.9M | $1.1B | 2009 |
Mickael Tukdarian at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mickael Tukdarian on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daniel C. Reese | 1 | 7 |
| Robert Monk | 1 | 5 |
| C. Morris Stout | 1 | 3 |
| Scott C. Emerson | 1 | 2 |
| Mark C. Poff | 1 | 1 |
| Michael C. Smith | 1 | 1 |
| Michael C. Westhusing | 1 | 1 |
| Kipp C. DeVeer | 1 | 1 |
| Kipp DeVeer | 1 | 1 |
| Mark Poff | 1 | 1 |
| Craig Hille | 1 | 1 |
| Joseph Suprenuk | 1 | 1 |
| James Berwick | 1 | 1 |
| Dennis Kinsey | 1 | 1 |
| Gary Downing | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.